Dr. Zhao’s work spans several areas of genomic epidemiology, including gene discovery, gene-environment interaction, epigenomics, transcriptomics, mitochondrial genomics, and risk prediction.
Dr. Zhao’s work spans several areas of genomic epidemiology, including gene discovery, gene-environment interaction, epigenomics, transcriptomics, mitochondrial genomics, and risk prediction.
Dr. Karvonen-Gutierrez’s research focuses on the impact of chronological aging, reproductive aging and obesity and their intersections. She also studies the development and progression of chronic disease and musculoskeletal outcomes through the creation of a metabolically-dysfunctional and pro-inflammatory environment.
Dr. Bakulski’s research focuses on the genetics of mental and cognitive health. She also has experience with heavy metals exposure assessment, particularly biomarkers of cumulative lead exposure. Dr. Bakulski’s current research integrates and applies multiple genome-wide measures to understand disease risk. In addition, she studies the interactions between multiple pollutant exposures and genetics in aging populations on the risk of cognitive decline.
Dr. Ware conducts high throughput statistical analysis of genomic data to study disparities by in psychiatric outcomes by race and sex. She also explores gene-environment interactions as determinants of chronic disease.